Apellis Pharmaceuticals Inc (APLS) Insider Trading
- $23,844,337.28
- $103,599,594.95
- Sept. 16, 2024
- Alec Machiels
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Sept. 16, 2024 | Director | 37,000 | $36.23 | Sell | $1,340,510.00 | |
June 21, 2024 | Director | 37,000 | $39.24 | Sell | $1,451,880.00 | |
May 8, 2024 | Insider | 78,907 | $42.35 | Sell | $3,341,711.45 | |
April 8, 2024 | Insider | 69,107 | $54.17 | Sell | $3,743,526.19 | |
April 1, 2024 | CFO | 4,000 | $58.66 | Sell | $234,640.00 | |
March 19, 2024 | Director | 18,681 | $57.18 | Sell | $1,068,179.58 | |
March 18, 2024 | Insider | 9,913 | $56.90 | Sell | $564,049.70 | |
March 15, 2024 | CAO | 184 | $56.46 | Sell | $10,388.64 | |
March 13, 2024 | Insider | 11,220 | $57.56 | Sell | $645,823.20 | |
March 1, 2024 | CFO | 6,000 | $63.22 | Sell | $379,320.00 | |
March 1, 2024 | CEO | 250,000 | $64.11 | Sell | $16,027,500.00 | |
Feb. 12, 2024 | CEO | 3,962 | $67.77 | Sell | $268,504.74 | |
Feb. 12, 2024 | General Counsel | 781 | $67.77 | Sell | $52,928.37 | |
Feb. 12, 2024 | Insider | 1,148 | $67.77 | Sell | $77,799.96 | |
Feb. 12, 2024 | CFO | 1,431 | $67.77 | Sell | $96,978.87 | |
Jan. 29, 2024 | General Counsel | 906 | $64.14 | Sell | $58,110.84 | |
Jan. 29, 2024 | CEO | 2,843 | $64.14 | Sell | $182,350.02 | |
Jan. 29, 2024 | Insider | 835 | $64.14 | Sell | $53,556.90 | |
Jan. 22, 2024 | General Counsel | 4,184 | $65.00 | Sell | $271,960.00 | |
Jan. 22, 2024 | CEO | 13,431 | $65.00 | Sell | $873,015.00 | |
Jan. 22, 2024 | Insider | 3,413 | $65.00 | Sell | $221,845.00 | |
Jan. 22, 2024 | CFO | 3,551 | $65.00 | Sell | $230,815.00 | |
Jan. 22, 2024 | CAO | 1,061 | $65.00 | Sell | $68,965.00 | |
Jan. 16, 2024 | General Counsel | 4,240 | $66.81 | Sell | $283,274.40 | |
Jan. 16, 2024 | CAO | 864 | $66.81 | Sell | $57,723.84 | |
Jan. 16, 2024 | CEO | 7,851 | $66.81 | Sell | $524,525.31 | |
Jan. 16, 2024 | CFO | 2,235 | $66.81 | Sell | $149,320.35 | |
Jan. 16, 2024 | Insider | 438 | $66.81 | Sell | $29,262.78 | |
Jan. 4, 2024 | Insider | 2,751 | $60.05 | Sell | $165,197.55 | |
Dec. 26, 2023 | Insider | 68 | $57.86 | Sell | $3,934.48 | |
Dec. 19, 2023 | General Counsel | 3,905 | $57.23 | Sell | $223,483.15 | |
Dec. 1, 2023 | Insider | 10,000 | $60.00 | Sell | $600,000.00 | |
Nov. 21, 2023 | CEO | 5,000 | $48.80 | Sell | $244,000.00 | |
Nov. 17, 2023 | Director | 1,250 | $47.74 | Sell | $59,675.00 | |
Nov. 8, 2023 | Insider | 12,000 | $47.27 | Sell | $567,240.00 | |
Oct. 23, 2023 | CAO | 132 | $46.04 | Sell | $6,077.28 | |
Oct. 23, 2023 | Insider | 131 | $46.04 | Sell | $6,031.24 | |
Oct. 17, 2023 | Director | 1,250 | $48.50 | Sell | $60,625.00 | |
Oct. 9, 2023 | Insider | 12,000 | $40.38 | Sell | $484,560.00 | |
Sept. 18, 2023 | Director | 1,250 | $45.00 | Sell | $56,250.00 | |
Sept. 18, 2023 | Insider | 20,350 | $44.27 | Sell | $900,894.50 | |
Sept. 15, 2023 | Director | 1,250 | $45.34 | Sell | $56,675.00 | |
Sept. 8, 2023 | Insider | 12,000 | $42.87 | Sell | $514,440.00 | |
Sept. 1, 2023 | CEO | 150,000 | $41.75 | Sell | $6,262,500.00 | |
Aug. 31, 2023 | CAO | 551 | $41.23 | Sell | $22,717.73 | |
Aug. 8, 2023 | Insider | 12,000 | $23.66 | Sell | $283,920.00 | |
July 17, 2023 | Director | 1,250 | $64.79 | Sell | $80,987.50 | |
July 10, 2023 | Insider | 12,000 | $84.55 | Sell | $1,014,600.00 | |
July 3, 2023 | CFO | 6,779 | $89.97 | Sell | $609,906.63 | |
July 3, 2023 | General Counsel | 8,510 | $89.98 | Sell | $765,729.80 |
Insiders are both buying and selling Apellis Pharmaceuticals Inc stock.
The insider traders at Apellis Pharmaceuticals Inc are: Alec Machiels, Federico Grossi, Cedric Francois, Pascal Deschatelets, A. Sinclair Dunlop, Mark Jeffrey Delong, David O Watson, Adam J Townsend, Lukas Scheibler, Timothy Eugene Sullivan, Nicole D Perry, James George Chopas, Jeffrey Eisele, Morningside Venture Investment, Karen Lewis, Nur Nicholson, Global Strategic Fund I Venbio, Victoria L. Brown, Deschatelets Pascal, Caroline Baumal, Victoria L Brown, and Machiels Alec
The most active insider trader at Apellis Pharmaceuticals Inc is Alec Machiels with 30 trades.
Cedric Francois has sold the most Apellis Pharmaceuticals Inc stock with a total value of $50,716,137.07.
Morningside Venture Investment has bought the most Apellis Pharmaceuticals Inc stock with a total value of $31,651,764.04.
The most recent insider trade for Apellis Pharmaceuticals Inc was on Sept. 16, 2024.
The single biggest insider buy for Apellis Pharmaceuticals Inc was from Morningside Venture Investment with a total value of $10,000,000.00 on Nov. 18, 2021.
The single biggest insider sell for Apellis Pharmaceuticals Inc was from Cedric Francois with a total value of $16,027,500.00 on March 1, 2024.